Common Contracts
3 similar Trial Agreement contracts
ZMLUVA O KLINICKOM SKÚŠANÍ CLINICAL TRIAL AGREEMENTTrial Agreement • November 14th, 2023
concluded pursuant to Section 269 (2) of Act no. 513/1991 of Coll., the Commercial Code, as amended (hereinafter referred to as the “Commercial Code”) (hereinafter referred to as the “Agreement”)
ZMLUVA O KLINICKOM SKÚŠANÍ CLINICAL TRIAL AGREEMENTTrial Agreement • September 27th, 2023
concluded pursuant to Section 269 (2) of Act no. 513/1991 of Coll., the Commercial Code, as amended (hereinafter referred to as the “Commercial Code”) (hereinafter referred to as the “Agreement”)
ContractTrial Agreement • January 3rd, 2023
ZMLUVA O KLINICKOM SKÚŠANÍ CLINICAL TRIAL AGREEMENT uzatvorená podľa § 269 ods. 2 a nasl. zákona č. 513/1991 Zb. Obchodný zákonník v platnom znení (ďalej len „Obchodný zákonník”) (ďalej len„Zmluva“) Medzi concluded pursuant to Section 269 (2) of Act no. 513/1991 of Coll., the Commercial Code, as amended (hereinafter referred to as the “Commercial Code”) (hereinafter referred to as the “Agreement”) Between Novartis Slovakia s.r.o.sídlo: Žižkova 22B, 811 02 BratislavaIČO: 36 723 304DIČ: 2022302425IČDPH: SK 2022302425zapísaný: v Obchodnom registriOkresného súdu Bratislava I, oddiel: Sro, vložka č. 44016/Bv mene ktorého koná/zastúpený:Mgr. Hana Mrázová, na základe plnomocenstva PharmDr. Katarína Nosjean, na základe plnomocenstva bankové spojenie:Tatra banka, a.s. SWIFT: TATRSKBXIBAN: SK8611000000002926123169 (ďalej len “Novartis”) Novartis Slovakia s.r.o.Registered office: Žižkova 22B, 811 02 Bratislava Company ID: 36 723 304Tax ID: 2022302425VAT ID: SK 2022302425Registration: Commercial R
